These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19279381)

  • 1. A short cycle of narrow-band UVB phototherapy in the early phase of long-term efalizumab can provide a quicker remission of moderate and severe psoriasis: a pilot study.
    Zane C; Capezzera R; Venturini M; Sala R; Facchinetti E; Pedretti A; Calzavara-Pinton P
    Dermatology; 2009; 218(4):321-6. PubMed ID: 19279381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of moderate to severe plaque psoriasis with concomitant efalizumab and narrow-band ultraviolet B phototherapy.
    Kircik LH; Liu C; Goffe BS
    J Drugs Dermatol; 2008 Oct; 7(10):947-52. PubMed ID: 19112758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis.
    Calzavara-Pinton PG; Sala R; Arisi M; Rossi MT; Venturini M; Ortel B
    Br J Dermatol; 2013 Jul; 169(1):130-6. PubMed ID: 23834117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, 'head-to-head' pilot study comparing the effects of etanercept monotherapy vs. etanercept and narrowband ultraviolet B (NB-UVB) phototherapy in obese psoriasis patients.
    Park KK; Wu JJ; Koo J
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):899-906. PubMed ID: 22702846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of the response to biological treatments using narrow band ultraviolet-B in patients with moderate to severe psoriasis: a retrospective study of 17 patients.
    Belinchón I; Arribas MP; Soro P; Betlloch I
    Photodermatol Photoimmunol Photomed; 2014 Dec; 30(6):316-22. PubMed ID: 25132192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative non randomized study of narrow-band (NB) (312 +/- 2 nm) UVB phototherapy versus sequential therapy with oral administration of low-dose Cyclosporin A and NB-UVB phototherapy in patients with severe psoriasis vulgaris.
    Calzavara-Pinton P; Leone G; Venturini M; Sala R; Colombo D; La Parola IL; Sitzia N; Ferraro C; Picardo M
    Eur J Dermatol; 2005; 15(6):470-3. PubMed ID: 16280301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apremilast and Narrowband Ultraviolet-B Combination Therapy for Treating Moderate-to-Severe Plaque Psoriasis.
    Bagel J; Nelson E; Keegan BR
    J Drugs Dermatol; 2017 Oct; 16(10):957-962. PubMed ID: 29036248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled study of combination therapy with alefacept and narrow band UVB phototherapy (UVB) for moderate to severe psoriasis: efficacy, onset, and duration of response.
    Lui H; Gulliver W; Tan J; Hong CH; Hull P; Shear NH; Paradiso-Hardy F; Bissonette R
    J Drugs Dermatol; 2012 Aug; 11(8):929-37. PubMed ID: 22859237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks.
    Gambichler T; Tigges C; Scola N; Weber J; Skrygan M; Bechara FG; Altmeyer P; Kreuter A
    Br J Dermatol; 2011 Jun; 164(6):1383-6. PubMed ID: 21466532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes.
    Kircik L; Bagel J; Korman N; Menter A; Elmets CA; Koo J; Yang YC; Chiou CF; Dann F; Stevens SR;
    J Drugs Dermatol; 2008 Mar; 7(3):245-53. PubMed ID: 18380206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment with etanercept 50 mg once weekly and narrow-band ultraviolet B phototherapy in chronic plaque psoriasis.
    De Simone C; D'Agostino M; Capizzi R; Capponi A; Venier A; Caldarola G
    Eur J Dermatol; 2011; 21(4):568-72. PubMed ID: 21697032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis.
    Menter A; Gordon K; Carey W; Hamilton T; Glazer S; Caro I; Li N; Gulliver W
    Arch Dermatol; 2005 Jan; 141(1):31-8. PubMed ID: 15655139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis.
    Ortonne JP; Khemis A; Koo JY; Choi J
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):556-63. PubMed ID: 16164708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis treatment: faster and long-standing results after bathing in geothermal seawater. A randomized trial of three UVB phototherapy regimens.
    Eysteinsdóttir JH; Ólafsson JH; Agnarsson BA; Lúðvíksson BR; Sigurgeirsson B
    Photodermatol Photoimmunol Photomed; 2014 Feb; 30(1):25-34. PubMed ID: 24255991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sitagliptin and Narrow-Band Ultraviolet-B for Moderate Psoriasis (DINUP): A Randomised Controlled Clinical Trial.
    Lynch M; Malara A; Timoney I; Vencken S; Ahern T; Awdeh F; Sweeney C; Galligan M; Kelly G; Hughes R; Murad A; Hambly R; O'Shea D; Doran P; Kirby B
    Dermatology; 2022; 238(1):140-147. PubMed ID: 33866313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of up to 15 months' efalizumab therapy in patients with moderate-to-severe chronic plaque psoriasis.
    Toth DP; Papp K; Gratton D
    Dermatol Ther; 2008; 21 Suppl 3():S6-14. PubMed ID: 19076630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis.
    Gottlieb AB; Gordon KB; Lebwohl MG; Caro I; Walicke PA; Li N; Leonardi CL;
    J Drugs Dermatol; 2004; 3(6):614-24. PubMed ID: 15624744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efalizumab therapy for patients with moderate-to-severe, chronic plaque psoriasis: results from an Australian expanded access program.
    Foley P; Freeman M; Gebauer K; Murrell D; Shumack S; Tyson C; Varigos G
    Int J Dermatol; 2009 Dec; 48(12):1376-84. PubMed ID: 19930495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of combination treatment with narrowband UVB (TL-01) and acitretin vs narrowband UVB alone in plaque-type psoriasis: a retrospective study.
    Kampitak T; Asawanonda P
    J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S20-4. PubMed ID: 17718265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical effects of psoriasis treatment regimens among calcipotriol alone, narrowband ultraviolet B phototherapy alone, combination of calcipotriol and narrowband ultraviolet B phototherapy once a week, and combination of calcipotriol and narrowband ultraviolet B phototherapy more than twice a week.
    Takahashi H; Tsuji H; Ishida-Yamamoto A; Iizuka H
    J Dermatol; 2013 Jun; 40(6):424-7. PubMed ID: 23414298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.